✦ LIBER ✦

Exploring the effects of luteinizing hormone–releasing hormone agonist therapy on bone health: implications in the management of prostate cancer

✍ Scribed by SAM S Chang

Book ID: 116943952
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 169 KB
Volume: 62
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2003.10.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Luteinizing hormone releasing hormone ag

Luteinizing hormone releasing hormone agonist in the treatment of advanced prostatic cancer

✍ P. Kellokumpu-Lehtinen; R. Valavaara 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Chemohormonal therapy as primary treatme

Chemohormonal therapy as primary treatment for metastatic prostate cancer: A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist

✍ MASANORI NOGUCHI; SHINSHI NODA; MASAKI YOSHIDA; SHOICHI UEDA; TAIZO SHIRAISHI; K 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Risedronate prevents early bone loss and

Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer

✍ Pamela Taxel; Robert Dowsett; Lee Richter; Pamela Fall; Alison Klepinger; Peter 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

Bone fractures associated with luteinizi

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

✍ Murphy F. Townsend; W. Holt Sanders; Robert O. Northway; Sam D. Graham Jr. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Background: Luteinizing hormone-releasing hormone agonists (lhrh-a) have become an established treatment for certain patients with prostate carcinoma. lhrh-a are known to decrease bone mineral density. the purpose of this study was to determine the risk of bone fracture in men receiving lhrh-a f

Role of Luteinising Hormone Releasing Ho

Role of Luteinising Hormone Releasing Hormone (LHRH) Agonists and Hormonal Treatment in the Management of Prostate Cancer

✍ P. Mongiat-Artus; P. Teillac 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Prospective determination of the hormona

Prospective determination of the hormonal response after cessation of luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer

✍ M.Craig Hall; Ralph J Fritzsch; Arthur I Sagalowsky; Allison Ahrens; Beth Petty; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 110 KB